REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bon Pharma Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: BON PHARMA Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Bon Pharma Kft is a company that specializes in products for diabetics, including blood sugar measuring devices, test stripes, and insulin. It is one of the largest domestic distributors in Hungary and has a team of employees who support people with type 2 diabetes. The company has recently become the exclusive importer of Curalife's products in Hungary.

Headquarters
Akacfa utca 5. 2. em. 8.
Budapest; Budapest; Postal Code: 1214

Contact Details: Purchase the Bon Pharma Kft. report to view the information.

Website: http://www.bonpharma.hu

Basic Information
Total Employees:
Purchase the Bon Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Bon Pharma Kft. report to view the information.
Registered Capital:
Purchase the Bon Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Bon Pharma Kft. report to view the information.
Incorporation Date:
January 28, 2009
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bon Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
27.92%▲
Total operating revenue
27.76%▲
Operating profit (EBIT)
59.73%▲
EBITDA
58.99%▲
Net Profit (Loss) for the Period
110.48%▲
Total assets
50.33%▲
Total equity
90.36%▲
Operating Profit Margin (ROS)
0.26%▲
Net Profit Margin
0.47%▲
Return on Equity (ROE)
6.21%▲
Quick Ratio
-0.17%▼
Cash Ratio
-0.17%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo